Systems Biology Opens New Research Pathways
Systems Biologists Are Attacking the Encrypted Messages That Would Allow Us to Predict and Change the Course of Disease
Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
For full access to this article login to GEN Select now.
Leveraging Synthetic Lethality for Cancer
Researchers Investigating a Class of Drugs that Could Short-Circuit Cancer Cells at Molecular Level
- For the past few years, drugs exploiting synthetic lethality have gained attention as novel anticancer agents. Breast and ovarian cancers with mutated BRCA1 or 2, essential components of a pathway for repairing DNA double-strand breaks, provide a fundamental example of how synthetic lethality works. Because replicating DNA requires ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.